{"protocolSection": {"identificationModule": {"nctId": "NCT00536731", "orgStudyIdInfo": {"id": "D5897C00003"}, "organization": {"fullName": "AstraZeneca", "class": "INDUSTRY"}, "briefTitle": "Symbicort Rapihaler Therapeutic Equivalence Study", "officialTitle": "A 6-week, Phase III, Double-blind, Randomized, Multi-centre, Parallel-group Study Evaluating the Efficacy and Safety of 2 Actuations Symbicort\u00aepMDI\u00ae 40/2.25 \u03bcg Twice Daily Compared With 1 Inhalation Symbicort Turbuhaler\u00ae 80/4.5 \u03bcg Twice Daily and 1 Inhalation Pulmicort\u00aeTurbuhaler\u00ae 100 \u03bcg Twice Daily", "acronym": "ESTHER"}, "statusModule": {"statusVerifiedDate": "2012-08", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2007-09"}, "primaryCompletionDateStruct": {"date": "2008-04", "type": "ACTUAL"}, "completionDateStruct": {"date": "2008-04", "type": "ACTUAL"}, "studyFirstSubmitDate": "2007-09-27", "studyFirstSubmitQcDate": "2007-09-27", "studyFirstPostDateStruct": {"date": "2007-09-28", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2009-04-01", "resultsFirstSubmitQcDate": "2012-08-14", "resultsFirstPostDateStruct": {"date": "2012-08-15", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2012-08-14", "lastUpdatePostDateStruct": {"date": "2012-08-15", "type": "ESTIMATED"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "AstraZeneca", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": false}, "descriptionModule": {"briefSummary": "The purpose of the this study is to evaluate the efficacy and safety of 2 actuations Symbicort\u00aepMDI\u00ae 40/2.25 \u03bcg twice daily compared with1 inhalation Symbicort Turbuhaler\u00ae 80/4.5 \u03bcg twice daily and 1 inhalation Pulmicort\u00aeTurbuhaler\u00ae 100 \u03bcg twice daily for 6 weeks."}, "conditionsModule": {"conditions": ["Bronchial Asthma"], "keywords": ["Asthma", "Symbicort"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE3"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "QUADRUPLE", "whoMasked": ["PARTICIPANT", "CARE_PROVIDER", "INVESTIGATOR", "OUTCOMES_ASSESSOR"]}}, "enrollmentInfo": {"count": 742, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Symbicort pMDI", "type": "ACTIVE_COMPARATOR", "description": "Symbicort\u00aepMDI\u00ae 40/2.25 \u03bcg 2 Actuations Twice Daily", "interventionNames": ["Drug: Symbicort pMDI"]}, {"label": "Symbicort Turbuhaler", "type": "ACTIVE_COMPARATOR", "description": "Symbicort Turbuhaler\u00ae 80/4.5 \u03bcg 1 Inhalation Twice Daily", "interventionNames": ["Drug: Symbicort Turbuhaler"]}, {"label": "Pulmicort Turbuhaler", "type": "ACTIVE_COMPARATOR", "description": "Pulmicort\u00aeTurbuhaler\u00ae 100 \u03bcg 1 Inhalation Twice Daily", "interventionNames": ["Drug: Pulmicort Turbuhaler"]}], "interventions": [{"type": "DRUG", "name": "Symbicort Turbuhaler", "description": "Symbicort Turbuhaler\u00ae 80/4.5 \u03bcg 1 Inhalation Twice Daily", "armGroupLabels": ["Symbicort Turbuhaler"]}, {"type": "DRUG", "name": "Symbicort pMDI", "description": "Symbicort\u00aepMDI\u00ae 40/2.25 \u03bcg 2 Actuations Twice Daily", "armGroupLabels": ["Symbicort pMDI"]}, {"type": "DRUG", "name": "Pulmicort Turbuhaler", "description": "Pulmicort\u00aeTurbuhaler\u00ae 100 \u03bcg 1 Inhalation Twice Daily", "armGroupLabels": ["Pulmicort Turbuhaler"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Morning Peak Expiratory Flow (PEF)", "description": "Change in the Morning PEF from baseline (calculated as a mean using all available data for the 10 last days of run-in period) to week 6 (calculated as a mean using all available data after randomisation). No imputation of missing data was performed", "timeFrame": "Baseline to 6 weeks"}], "secondaryOutcomes": [{"measure": "Evening Peak Expiratory Flow (PEF)", "description": "Change in the Evening PEF from baseline (calculated as a mean using all available data for the 10 last days of run-in period) to week 6 (calculated as a mean using all available data after randomisation). No imputation of missing data was performed", "timeFrame": "Baseline to 6 weeks"}, {"measure": "Asthma Symptom Score, Night", "description": "Change in the Asthma Symptom Score (Night) from baseline (calculated as a mean using all available data for the 10 last days of run-in period) to week 6 (calculated as a mean using all available data after randomization, with run-in values as covariate). No imputation of missing data was performed. Daily scale:0 = No symptoms; 1 = Mild symptoms; 2 = Moderate symptoms; 3 = Severe symptoms.", "timeFrame": "Baseline to 6 weeks"}, {"measure": "Asthma Symptom Score, Day", "description": "Change in the Asthma Symptom Score (Day) from baseline (calculated as a mean using all available data for the 10 last days of run-in period) to week 6 (calculated as a mean using all available data after randomization, with run-in values as covariate). No imputation of missing data was performed. Daily scale:0 = No symptoms; 1 = Mild symptoms; 2 = Moderate symptoms; 3 = Severe symptoms.", "timeFrame": "Baseline to 6 weeks"}, {"measure": "Asthma Symptom Score, Total", "description": "Change in the Asthma Symptom Score (Total) from baseline (calculated as a mean using all available data for the 10 last days of run-in period) to week 6 (calculated as a mean using all available data after randomization, with run-in values as covariate). No imputation of missing data was performed. Daily scale:0 = No symptoms; 1 = Mild symptoms; 2 = Moderate symptoms; 3 = Severe symptoms.", "timeFrame": "Baseline to 6 weeks"}, {"measure": "Percentage of Nights With Awakenings Due to Asthma", "description": "Change in the Percentage of Nights With Awakenings Due to Asthma from baseline (calculated as a mean using all available data for the 10 last days of run-in period) to week 6 (calculated as a mean using all available data after randomization, with run-in values as covariate). No imputation of missing data was performed. The participants answered \"Yes\" or \"No\" whether she/he woke up during the night due to asthma.", "timeFrame": "Baseline and 6 weeks"}, {"measure": "Use of Rescue Medication, Night", "description": "Change in the Use of Rescue Medication (Night) from baseline (calculated as a mean using all available data for the 10 last days of run-in period) to week 6 (calculated as a mean using all available data after randomization, with run-in values as covariate). No imputation of missing data was performed", "timeFrame": "Baseline to 6 weeks"}, {"measure": "Use of Rescue Medication, Day", "description": "Change in the Use of Rescue Medication (Day) from baseline (calculated as a mean using all available data for the 10 last days of run-in period) to week 6 (calculated as a mean using all available data after randomization, with run-in values as covariate). No imputation of missing data was performed", "timeFrame": "Baseline to 6 weeks"}, {"measure": "Use of Rescue Medication, Total", "description": "Change in the Use of Rescue Medication (Total) from baseline (calculated as a mean using all available data for the 10 last days of run-in period) to week 6 (calculated as a mean using all available data after randomization, with run-in values as covariate). No imputation of missing data was performed", "timeFrame": "Baseline to 6 weeks"}, {"measure": "Percentage of Symptom-free Days", "description": "Change in the Percentage of Symptom-free Days from baseline (calculated as a mean using all available data for the 10 last days of run-in period) to week 6 (calculated as a mean using all available data after randomization, with run-in values as covariate). No imputation of missing data was performed. Symptom-free Day: no symptoms (asthma symptom score=0) night and day, and no awakenings due to asthma.", "timeFrame": "Baseline to 6 weeks"}, {"measure": "Percentage of Asthma Control Days", "description": "Change in the Percentage of Symptom Control Days from baseline (calculated as a mean using all available data for the 10 last days of run-in period) to week 6 (calculated as a mean using all available data after randomization, with run-in values as covariate). No imputation of missing data was performed. Asthma Control Day: no symptoms (asthma symptom score=0) night and day, no awakenings due to asthma, no rescue medication.", "timeFrame": "Baseline to 6 weeks"}, {"measure": "Percentage of Rescue Free Days", "description": "Change in the Percentage of Rescue Free Days from baseline (calculated as a mean using all available data for the 10 last days of run-in period) to week 6 (calculated as a mean using all available data after randomization, with run-in values as covariate). No imputation of missing data was performed. Rescue-free Day defined as day and night with no use of rescue medication.", "timeFrame": "Baseline to 6 weeks"}, {"measure": "Forced Expiratory Volume in 1 Second (FEV1)", "description": "Change in the FEV1from baseline to week 6 (calculated as a mean using all available data after randomization)", "timeFrame": "Baseline to 6 weeks"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Asthma clinically diagnosed since at least 6 months.\n* Lung function values measured \u2265 50% and \u2264 90% of predicted normal.\n* Patients with reversible airway obstruction Daily use of inhaled steroids (any brand) for \\>3 months.\n\nExclusion Criteria:\n\n* Use of oral, rectal or parenteral steroids within 30 days prior to start of study.\n* Respiratory infection affecting the asthma, as judged by the investigator, within 30 days prior to start of randomised treatment.\n* Any significant disease or disorder which, in the opinion of the investigator, may either put the patient at risk because of participation in the study, or may influence the results of the study or the patient's ability to participate in the study.", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "12 Years", "stdAges": ["CHILD", "ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Tomas Andersson", "affiliation": "AstraZeneca", "role": "STUDY_DIRECTOR"}, {"name": "Akos Somoskovi", "affiliation": "AstraZeneca", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "Research Site", "city": "Pleven", "country": "Bulgaria", "geoPoint": {"lat": 43.41667, "lon": 24.61667}}, {"facility": "Research Site", "city": "Plovdiv", "country": "Bulgaria", "geoPoint": {"lat": 42.15, "lon": 24.75}}, {"facility": "Research Site", "city": "Rousse", "country": "Bulgaria", "geoPoint": {"lat": 43.85639, "lon": 25.97083}}, {"facility": "Research Site", "city": "Sofia", "country": "Bulgaria", "geoPoint": {"lat": 42.69751, "lon": 23.32415}}, {"facility": "Research Site", "city": "Varna", "country": "Bulgaria", "geoPoint": {"lat": 43.21667, "lon": 27.91667}}, {"facility": "Research Site", "city": "Benesov U Prahy", "country": "Czech Republic"}, {"facility": "Research Site", "city": "Hradec Kralove", "country": "Czech Republic", "geoPoint": {"lat": 50.20923, "lon": 15.83277}}, {"facility": "Research Site", "city": "Jihlava", "country": "Czech Republic", "geoPoint": {"lat": 49.3961, "lon": 15.59124}}, {"facility": "Research Site", "city": "Kladno", "country": "Czech Republic", "geoPoint": {"lat": 50.14734, "lon": 14.10285}}, {"facility": "Research Site", "city": "Kolin", "country": "Czech Republic", "geoPoint": {"lat": 50.02806, "lon": 15.1998}}, {"facility": "Research Site", "city": "Kutna Hora", "country": "Czech Republic", "geoPoint": {"lat": 49.94839, "lon": 15.26816}}, {"facility": "Research Site", "city": "Litomerice", "country": "Czech Republic", "geoPoint": {"lat": 50.53348, "lon": 14.1318}}, {"facility": "Research Site", "city": "Neratovice", "country": "Czech Republic", "geoPoint": {"lat": 50.25926, "lon": 14.51759}}, {"facility": "Research Site", "city": "Pardubice", "country": "Czech Republic", "geoPoint": {"lat": 50.04075, "lon": 15.77659}}, {"facility": "Research Site", "city": "Praha 4", "country": "Czech Republic", "geoPoint": {"lat": 50.08804, "lon": 14.42076}}, {"facility": "Research Site", "city": "Praha 5", "country": "Czech Republic", "geoPoint": {"lat": 50.08804, "lon": 14.42076}}, {"facility": "Research Site", "city": "Praha 8", "country": "Czech Republic", "geoPoint": {"lat": 50.08804, "lon": 14.42076}}, {"facility": "Research Site", "city": "Rokycany", "country": "Czech Republic", "geoPoint": {"lat": 49.7427, "lon": 13.59459}}, {"facility": "Research Site", "city": "Strakonice", "country": "Czech Republic", "geoPoint": {"lat": 49.26141, "lon": 13.90237}}, {"facility": "Research Site", "city": "Balassagyarmat", "country": "Hungary", "geoPoint": {"lat": 48.07296, "lon": 19.29614}}, {"facility": "Research Site", "city": "Budapest", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"facility": "Research Site", "city": "Cegl\u00e9d", "country": "Hungary", "geoPoint": {"lat": 47.17266, "lon": 19.79952}}, {"facility": "Research Site", "city": "Debrecen", "country": "Hungary", "geoPoint": {"lat": 47.53333, "lon": 21.63333}}, {"facility": "Research Site", "city": "Deszk", "country": "Hungary", "geoPoint": {"lat": 46.21802, "lon": 20.24322}}, {"facility": "Research Site", "city": "Gyor", "country": "Hungary", "geoPoint": {"lat": 47.68333, "lon": 17.63512}}, {"facility": "Research Site", "city": "Gyula", "country": "Hungary", "geoPoint": {"lat": 46.65, "lon": 21.28333}}, {"facility": "Research Site", "city": "Kaposvar", "country": "Hungary", "geoPoint": {"lat": 46.36667, "lon": 17.8}}, {"facility": "Research Site", "city": "Ny\u00edregyh\u00e1za", "country": "Hungary", "geoPoint": {"lat": 47.95539, "lon": 21.71671}}, {"facility": "Research Site", "city": "Szarvas", "country": "Hungary", "geoPoint": {"lat": 46.86667, "lon": 20.55}}, {"facility": "Research Site", "city": "Szeged", "country": "Hungary", "geoPoint": {"lat": 46.253, "lon": 20.14824}}, {"facility": "Research Site", "city": "Sz\u00e1zhalombatta", "country": "Hungary", "geoPoint": {"lat": 47.32579, "lon": 18.92141}}, {"facility": "Research Site", "city": "T\u00f6r\u00f6kb\u00e1lint", "country": "Hungary", "geoPoint": {"lat": 47.42931, "lon": 18.91356}}, {"facility": "Research Site", "city": "Bialystok", "country": "Poland", "geoPoint": {"lat": 53.13333, "lon": 23.16433}}, {"facility": "Research Site", "city": "Bielsko-biala", "country": "Poland", "geoPoint": {"lat": 49.82245, "lon": 19.04686}}, {"facility": "Research Site", "city": "Bydgoszcz", "country": "Poland", "geoPoint": {"lat": 53.1235, "lon": 18.00762}}, {"facility": "Research Site", "city": "Chodziez", "country": "Poland", "geoPoint": {"lat": 52.99505, "lon": 16.9198}}, {"facility": "Research Site", "city": "Chrzanow", "country": "Poland", "geoPoint": {"lat": 50.13546, "lon": 19.40203}}, {"facility": "Research Site", "city": "Karpacz", "country": "Poland", "geoPoint": {"lat": 50.77669, "lon": 15.75594}}, {"facility": "Research Site", "city": "Krakow", "country": "Poland", "geoPoint": {"lat": 50.06143, "lon": 19.93658}}, {"facility": "Research Site", "city": "Lodz", "country": "Poland", "geoPoint": {"lat": 51.75, "lon": 19.46667}}, {"facility": "Research Site", "city": "Lomza", "country": "Poland", "geoPoint": {"lat": 53.17806, "lon": 22.05935}}, {"facility": "Research Site", "city": "Lublin", "country": "Poland", "geoPoint": {"lat": 51.25, "lon": 22.56667}}, {"facility": "Research Site", "city": "Ostrow Wielkopolski", "country": "Poland", "geoPoint": {"lat": 51.65501, "lon": 17.80686}}, {"facility": "Research Site", "city": "Poznan", "country": "Poland", "geoPoint": {"lat": 52.40692, "lon": 16.92993}}, {"facility": "Research Site", "city": "Skierniewice", "country": "Poland", "geoPoint": {"lat": 51.95485, "lon": 20.15837}}, {"facility": "Research Site", "city": "Szczecin", "country": "Poland", "geoPoint": {"lat": 53.42894, "lon": 14.55302}}, {"facility": "Research Site", "city": "Tarnow", "country": "Poland", "geoPoint": {"lat": 50.01381, "lon": 20.98698}}, {"facility": "Research Site", "city": "Turek", "country": "Poland", "geoPoint": {"lat": 52.01548, "lon": 18.50055}}, {"facility": "Research Site", "city": "Wodzislaw Slaski", "country": "Poland", "geoPoint": {"lat": 50.00377, "lon": 18.47205}}, {"facility": "Research Site", "city": "Wroclaw", "country": "Poland", "geoPoint": {"lat": 51.1, "lon": 17.03333}}]}}, "resultsSection": {"participantFlowModule": {"recruitmentDetails": "898 subjects enrolled; 156 not randomised: 94 incorrect enrolment, 9 adverse events, 18 voluntary discontinuations, 1 lost to follow-up, 1use of not allowed medication, 1 non-compliant", "groups": [{"id": "FG000", "title": "Symbicort pMDI", "description": "Symbicort\u00aepMDI\u00ae 40/2.25 \u03bcg 2 Actuations Twice Daily"}, {"id": "FG001", "title": "Symbicort Turbuhaler", "description": "Symbicort Turbuhaler\u00ae 80/4.5 \u03bcg 1 Inhalation Twice Daily"}, {"id": "FG002", "title": "Pulmicort Turbuhaler", "description": "Pulmicort\u00aeTurbuhaler\u00ae 100 \u03bcg 1 Inhalation Twice Daily"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "253"}, {"groupId": "FG001", "numSubjects": "246"}, {"groupId": "FG002", "numSubjects": "243"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "249"}, {"groupId": "FG001", "numSubjects": "241"}, {"groupId": "FG002", "numSubjects": "238"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "4"}, {"groupId": "FG001", "numSubjects": "5"}, {"groupId": "FG002", "numSubjects": "5"}]}], "dropWithdraws": [{"type": "Adverse Event", "reasons": [{"groupId": "FG000", "numSubjects": "3"}, {"groupId": "FG001", "numSubjects": "2"}, {"groupId": "FG002", "numSubjects": "3"}]}, {"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "2"}, {"groupId": "FG002", "numSubjects": "0"}]}, {"type": "Intake of prohibited conc. medication", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "1"}]}, {"type": "Safety reasons", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "1"}]}, {"type": "Other", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Symbicort pMDI", "description": "Symbicort\u00aepMDI\u00ae 40/2.25 \u03bcg 2 Actuations Twice Daily"}, {"id": "BG001", "title": "Symbicort Turbuhaler", "description": "Symbicort Turbuhaler\u00ae 80/4.5 \u03bcg 1 Inhalation Twice Daily"}, {"id": "BG002", "title": "Pulmicort Turbuhaler", "description": "Pulmicort\u00aeTurbuhaler\u00ae 100 \u03bcg 1 Inhalation Twice Daily"}, {"id": "BG003", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "253"}, {"groupId": "BG001", "value": "246"}, {"groupId": "BG002", "value": "243"}, {"groupId": "BG003", "value": "742"}]}], "measures": [{"title": "Age Continuous", "paramType": "MEAN", "dispersionType": "FULL_RANGE", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "41", "lowerLimit": "12", "upperLimit": "75"}, {"groupId": "BG001", "value": "42", "lowerLimit": "12", "upperLimit": "76"}, {"groupId": "BG002", "value": "39", "lowerLimit": "12", "upperLimit": "78"}, {"groupId": "BG003", "value": "41", "lowerLimit": "12", "upperLimit": "78"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "152"}, {"groupId": "BG001", "value": "142"}, {"groupId": "BG002", "value": "131"}, {"groupId": "BG003", "value": "425"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "101"}, {"groupId": "BG001", "value": "104"}, {"groupId": "BG002", "value": "112"}, {"groupId": "BG003", "value": "317"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Morning Peak Expiratory Flow (PEF)", "description": "Change in the Morning PEF from baseline (calculated as a mean using all available data for the 10 last days of run-in period) to week 6 (calculated as a mean using all available data after randomisation). No imputation of missing data was performed", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Liters/min", "timeFrame": "Baseline to 6 weeks", "groups": [{"id": "OG000", "title": "Symbicort pMDI", "description": "Symbicort\u00aepMDI\u00ae 40/2.25 \u03bcg 2 Actuations Twice Daily"}, {"id": "OG001", "title": "Symbicort Turbuhaler", "description": "Symbicort Turbuhaler\u00ae 80/4.5 \u03bcg 1 Inhalation Twice Daily"}, {"id": "OG002", "title": "Pulmicort Turbuhaler", "description": "Pulmicort\u00aeTurbuhaler\u00ae 100 \u03bcg 1 Inhalation Twice Daily"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "253"}, {"groupId": "OG001", "value": "245"}, {"groupId": "OG002", "value": "243"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "12.88", "spread": "24.6"}, {"groupId": "OG001", "value": "13.78", "spread": "29.7"}, {"groupId": "OG002", "value": "4.59", "spread": "27.9"}]}]}]}, {"type": "SECONDARY", "title": "Evening Peak Expiratory Flow (PEF)", "description": "Change in the Evening PEF from baseline (calculated as a mean using all available data for the 10 last days of run-in period) to week 6 (calculated as a mean using all available data after randomisation). No imputation of missing data was performed", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Liters/min", "timeFrame": "Baseline to 6 weeks", "groups": [{"id": "OG000", "title": "Symbicort pMDI", "description": "Symbicort\u00aepMDI\u00ae 40/2.25 \u03bcg 2 Actuations Twice Daily"}, {"id": "OG001", "title": "Symbicort Turbuhaler", "description": "Symbicort Turbuhaler\u00ae 80/4.5 \u03bcg 1 Inhalation Twice Daily"}, {"id": "OG002", "title": "Pulmicort Turbuhaler", "description": "Pulmicort\u00aeTurbuhaler\u00ae 100 \u03bcg 1 Inhalation Twice Daily"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "253"}, {"groupId": "OG001", "value": "245"}, {"groupId": "OG002", "value": "243"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "12.34", "spread": "24.3"}, {"groupId": "OG001", "value": "10.80", "spread": "29.1"}, {"groupId": "OG002", "value": "1.43", "spread": "25.7"}]}]}]}, {"type": "SECONDARY", "title": "Asthma Symptom Score, Night", "description": "Change in the Asthma Symptom Score (Night) from baseline (calculated as a mean using all available data for the 10 last days of run-in period) to week 6 (calculated as a mean using all available data after randomization, with run-in values as covariate). No imputation of missing data was performed. Daily scale:0 = No symptoms; 1 = Mild symptoms; 2 = Moderate symptoms; 3 = Severe symptoms.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Units on a scale", "timeFrame": "Baseline to 6 weeks", "groups": [{"id": "OG000", "title": "Symbicort pMDI", "description": "Symbicort\u00aepMDI\u00ae 40/2.25 \u03bcg 2 Actuations Twice Daily"}, {"id": "OG001", "title": "Symbicort Turbuhaler", "description": "Symbicort Turbuhaler\u00ae 80/4.5 \u03bcg 1 Inhalation Twice Daily"}, {"id": "OG002", "title": "Pulmicort Turbuhaler", "description": "Pulmicort\u00aeTurbuhaler\u00ae 100 \u03bcg 1 Inhalation Twice Daily"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "253"}, {"groupId": "OG001", "value": "245"}, {"groupId": "OG002", "value": "243"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.24", "spread": "0.41"}, {"groupId": "OG001", "value": "-0.27", "spread": "0.41"}, {"groupId": "OG002", "value": "-0.15", "spread": "0.39"}]}]}]}, {"type": "SECONDARY", "title": "Asthma Symptom Score, Day", "description": "Change in the Asthma Symptom Score (Day) from baseline (calculated as a mean using all available data for the 10 last days of run-in period) to week 6 (calculated as a mean using all available data after randomization, with run-in values as covariate). No imputation of missing data was performed. Daily scale:0 = No symptoms; 1 = Mild symptoms; 2 = Moderate symptoms; 3 = Severe symptoms.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Units on a scale", "timeFrame": "Baseline to 6 weeks", "groups": [{"id": "OG000", "title": "Symbicort pMDI", "description": "Symbicort\u00aepMDI\u00ae 40/2.25 \u03bcg 2 Actuations Twice Daily"}, {"id": "OG001", "title": "Symbicort Turbuhaler", "description": "Symbicort Turbuhaler\u00ae 80/4.5 \u03bcg 1 Inhalation Twice Daily"}, {"id": "OG002", "title": "Pulmicort Turbuhaler", "description": "Pulmicort\u00aeTurbuhaler\u00ae 100 \u03bcg 1 Inhalation Twice Daily"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "253"}, {"groupId": "OG001", "value": "245"}, {"groupId": "OG002", "value": "243"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.21", "spread": "0.38"}, {"groupId": "OG001", "value": "-0.24", "spread": "0.40"}, {"groupId": "OG002", "value": "-0.15", "spread": "0.40"}]}]}]}, {"type": "SECONDARY", "title": "Asthma Symptom Score, Total", "description": "Change in the Asthma Symptom Score (Total) from baseline (calculated as a mean using all available data for the 10 last days of run-in period) to week 6 (calculated as a mean using all available data after randomization, with run-in values as covariate). No imputation of missing data was performed. Daily scale:0 = No symptoms; 1 = Mild symptoms; 2 = Moderate symptoms; 3 = Severe symptoms.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Units on a scale", "timeFrame": "Baseline to 6 weeks", "groups": [{"id": "OG000", "title": "Symbicort pMDI", "description": "Symbicort\u00aepMDI\u00ae 40/2.25 \u03bcg 2 Actuations Twice Daily"}, {"id": "OG001", "title": "Symbicort Turbuhaler", "description": "Symbicort Turbuhaler\u00ae 80/4.5 \u03bcg 1 Inhalation Twice Daily"}, {"id": "OG002", "title": "Pulmicort Turbuhaler", "description": "Pulmicort\u00aeTurbuhaler\u00ae 100 \u03bcg 1 Inhalation Twice Daily"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "253"}, {"groupId": "OG001", "value": "245"}, {"groupId": "OG002", "value": "243"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.45", "spread": "0.73"}, {"groupId": "OG001", "value": "-0.51", "spread": "0.75"}, {"groupId": "OG002", "value": "-0.30", "spread": "0.73"}]}]}]}, {"type": "SECONDARY", "title": "Percentage of Nights With Awakenings Due to Asthma", "description": "Change in the Percentage of Nights With Awakenings Due to Asthma from baseline (calculated as a mean using all available data for the 10 last days of run-in period) to week 6 (calculated as a mean using all available data after randomization, with run-in values as covariate). No imputation of missing data was performed. The participants answered \"Yes\" or \"No\" whether she/he woke up during the night due to asthma.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Percentage of night", "timeFrame": "Baseline and 6 weeks", "groups": [{"id": "OG000", "title": "Symbicort pMDI", "description": "Symbicort\u00aepMDI\u00ae 40/2.25 \u03bcg 2 Actuations Twice Daily"}, {"id": "OG001", "title": "Symbicort Turbuhaler", "description": "Symbicort Turbuhaler\u00ae 80/4.5 \u03bcg 1 Inhalation Twice Daily"}, {"id": "OG002", "title": "Pulmicort Turbuhaler", "description": "Pulmicort\u00aeTurbuhaler\u00ae 100 \u03bcg 1 Inhalation Twice Daily"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "253"}, {"groupId": "OG001", "value": "245"}, {"groupId": "OG002", "value": "243"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-14.0", "spread": "24.1"}, {"groupId": "OG001", "value": "-14.0", "spread": "26.4"}, {"groupId": "OG002", "value": "-8.3", "spread": "25.5"}]}]}]}, {"type": "SECONDARY", "title": "Use of Rescue Medication, Night", "description": "Change in the Use of Rescue Medication (Night) from baseline (calculated as a mean using all available data for the 10 last days of run-in period) to week 6 (calculated as a mean using all available data after randomization, with run-in values as covariate). No imputation of missing data was performed", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Inhalations", "timeFrame": "Baseline to 6 weeks", "groups": [{"id": "OG000", "title": "Symbicort pMDI", "description": "Symbicort\u00aepMDI\u00ae 40/2.25 \u03bcg 2 Actuations Twice Daily"}, {"id": "OG001", "title": "Symbicort Turbuhaler", "description": "Symbicort Turbuhaler\u00ae 80/4.5 \u03bcg 1 Inhalation Twice Daily"}, {"id": "OG002", "title": "Pulmicort Turbuhaler", "description": "Pulmicort\u00aeTurbuhaler\u00ae 100 \u03bcg 1 Inhalation Twice Daily"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "253"}, {"groupId": "OG001", "value": "245"}, {"groupId": "OG002", "value": "243"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.41", "spread": "0.64"}, {"groupId": "OG001", "value": "-0.39", "spread": "0.76"}, {"groupId": "OG002", "value": "-0.19", "spread": "0.67"}]}]}]}, {"type": "SECONDARY", "title": "Use of Rescue Medication, Day", "description": "Change in the Use of Rescue Medication (Day) from baseline (calculated as a mean using all available data for the 10 last days of run-in period) to week 6 (calculated as a mean using all available data after randomization, with run-in values as covariate). No imputation of missing data was performed", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Inhalations", "timeFrame": "Baseline to 6 weeks", "groups": [{"id": "OG000", "title": "Symbicort pMDI", "description": "Symbicort\u00aepMDI\u00ae 40/2.25 \u03bcg 2 Actuations Twice Daily"}, {"id": "OG001", "title": "Symbicort Turbuhaler", "description": "Symbicort Turbuhaler\u00ae 80/4.5 \u03bcg 1 Inhalation Twice Daily"}, {"id": "OG002", "title": "Pulmicort Turbuhaler", "description": "Pulmicort\u00aeTurbuhaler\u00ae 100 \u03bcg 1 Inhalation Twice Daily"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "253"}, {"groupId": "OG001", "value": "245"}, {"groupId": "OG002", "value": "243"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.21", "spread": "0.39"}, {"groupId": "OG001", "value": "-0.20", "spread": "0.47"}, {"groupId": "OG002", "value": "-0.13", "spread": "0.56"}]}]}]}, {"type": "SECONDARY", "title": "Use of Rescue Medication, Total", "description": "Change in the Use of Rescue Medication (Total) from baseline (calculated as a mean using all available data for the 10 last days of run-in period) to week 6 (calculated as a mean using all available data after randomization, with run-in values as covariate). No imputation of missing data was performed", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Inhalations", "timeFrame": "Baseline to 6 weeks", "groups": [{"id": "OG000", "title": "Symbicort pMDI", "description": "Symbicort\u00aepMDI\u00ae 40/2.25 \u03bcg 2 Actuations Twice Daily"}, {"id": "OG001", "title": "Symbicort Turbuhaler", "description": "Symbicort Turbuhaler\u00ae 80/4.5 \u03bcg 1 Inhalation Twice Daily"}, {"id": "OG002", "title": "Pulmicort Turbuhaler", "description": "Pulmicort\u00aeTurbuhaler\u00ae 100 \u03bcg 1 Inhalation Twice Daily"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "253"}, {"groupId": "OG001", "value": "245"}, {"groupId": "OG002", "value": "243"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.62", "spread": "0.89"}, {"groupId": "OG001", "value": "-0.58", "spread": "1.09"}, {"groupId": "OG002", "value": "-0.32", "spread": "1.12"}]}]}]}, {"type": "SECONDARY", "title": "Percentage of Symptom-free Days", "description": "Change in the Percentage of Symptom-free Days from baseline (calculated as a mean using all available data for the 10 last days of run-in period) to week 6 (calculated as a mean using all available data after randomization, with run-in values as covariate). No imputation of missing data was performed. Symptom-free Day: no symptoms (asthma symptom score=0) night and day, and no awakenings due to asthma.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Percentage of days", "timeFrame": "Baseline to 6 weeks", "groups": [{"id": "OG000", "title": "Symbicort pMDI", "description": "Symbicort\u00aepMDI\u00ae 40/2.25 \u03bcg 2 Actuations Twice Daily"}, {"id": "OG001", "title": "Symbicort Turbuhaler", "description": "Symbicort Turbuhaler\u00ae 80/4.5 \u03bcg 1 Inhalation Twice Daily"}, {"id": "OG002", "title": "Pulmicort Turbuhaler", "description": "Pulmicort\u00aeTurbuhaler\u00ae 100 \u03bcg 1 Inhalation Twice Daily"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "253"}, {"groupId": "OG001", "value": "245"}, {"groupId": "OG002", "value": "243"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "12.5", "spread": "23.7"}, {"groupId": "OG001", "value": "15.3", "spread": "24.5"}, {"groupId": "OG002", "value": "9.1", "spread": "21.2"}]}]}]}, {"type": "SECONDARY", "title": "Percentage of Asthma Control Days", "description": "Change in the Percentage of Symptom Control Days from baseline (calculated as a mean using all available data for the 10 last days of run-in period) to week 6 (calculated as a mean using all available data after randomization, with run-in values as covariate). No imputation of missing data was performed. Asthma Control Day: no symptoms (asthma symptom score=0) night and day, no awakenings due to asthma, no rescue medication.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Percentage of days", "timeFrame": "Baseline to 6 weeks", "groups": [{"id": "OG000", "title": "Symbicort pMDI", "description": "Symbicort\u00aepMDI\u00ae 40/2.25 \u03bcg 2 Actuations Twice Daily"}, {"id": "OG001", "title": "Symbicort Turbuhaler", "description": "Symbicort Turbuhaler\u00ae 80/4.5 \u03bcg 1 Inhalation Twice Daily"}, {"id": "OG002", "title": "Pulmicort Turbuhaler", "description": "Pulmicort\u00aeTurbuhaler\u00ae 100 \u03bcg 1 Inhalation Twice Daily"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "253"}, {"groupId": "OG001", "value": "245"}, {"groupId": "OG002", "value": "243"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "12.7", "spread": "23.6"}, {"groupId": "OG001", "value": "15.1", "spread": "24.4"}, {"groupId": "OG002", "value": "9.1", "spread": "21.2"}]}]}]}, {"type": "SECONDARY", "title": "Percentage of Rescue Free Days", "description": "Change in the Percentage of Rescue Free Days from baseline (calculated as a mean using all available data for the 10 last days of run-in period) to week 6 (calculated as a mean using all available data after randomization, with run-in values as covariate). No imputation of missing data was performed. Rescue-free Day defined as day and night with no use of rescue medication.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Percentage of days", "timeFrame": "Baseline to 6 weeks", "groups": [{"id": "OG000", "title": "Symbicort pMDI", "description": "Symbicort\u00aepMDI\u00ae 40/2.25 \u03bcg 2 Actuations Twice Daily"}, {"id": "OG001", "title": "Symbicort Turbuhaler", "description": "Symbicort Turbuhaler\u00ae 80/4.5 \u03bcg 1 Inhalation Twice Daily"}, {"id": "OG002", "title": "Pulmicort Turbuhaler", "description": "Pulmicort\u00aeTurbuhaler\u00ae 100 \u03bcg 1 Inhalation Twice Daily"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "253"}, {"groupId": "OG001", "value": "245"}, {"groupId": "OG002", "value": "243"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "24.0", "spread": "30.9"}, {"groupId": "OG001", "value": "26.2", "spread": "30.7"}, {"groupId": "OG002", "value": "17.2", "spread": "28.4"}]}]}]}, {"type": "SECONDARY", "title": "Forced Expiratory Volume in 1 Second (FEV1)", "description": "Change in the FEV1from baseline to week 6 (calculated as a mean using all available data after randomization)", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Liters", "timeFrame": "Baseline to 6 weeks", "groups": [{"id": "OG000", "title": "Symbicort pMDI", "description": "Symbicort\u00aepMDI\u00ae 40/2.25 \u03bcg 2 Actuations Twice Daily"}, {"id": "OG001", "title": "Symbicort Turbuhaler", "description": "Symbicort Turbuhaler\u00ae 80/4.5 \u03bcg 1 Inhalation Twice Daily"}, {"id": "OG002", "title": "Pulmicort Turbuhaler", "description": "Pulmicort\u00aeTurbuhaler\u00ae 100 \u03bcg 1 Inhalation Twice Daily"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "253"}, {"groupId": "OG001", "value": "243"}, {"groupId": "OG002", "value": "242"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.095", "spread": "0.328"}, {"groupId": "OG001", "value": "0.147", "spread": "0.364"}, {"groupId": "OG002", "value": "0.112", "spread": "0.326"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "5", "eventGroups": [{"id": "EG000", "title": "Symbicort pMDI", "description": "Symbicort pMDI", "seriousNumAffected": 0, "seriousNumAtRisk": 253, "otherNumAffected": 0, "otherNumAtRisk": 253}, {"id": "EG001", "title": "Symbicort Turbuhaler", "description": "Symbicort Turbuhaler", "seriousNumAffected": 1, "seriousNumAtRisk": 246, "otherNumAffected": 0, "otherNumAtRisk": 246}, {"id": "EG002", "title": "Pulmicort Turbuhaler", "description": "Pulmicort Turbuhaler", "seriousNumAffected": 1, "seriousNumAtRisk": 243, "otherNumAffected": 0, "otherNumAtRisk": 243}], "seriousEvents": [{"term": "Asthma", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 10.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 253}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 246}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 243}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "Gerard Lynch", "organization": "AstraZeneca", "email": "aztrial_results_posting@astrazeneca.com"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000001249", "term": "Asthma"}], "ancestors": [{"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}], "browseLeaves": [{"id": "M27137", "name": "Respiratory Aspiration", "relevance": "LOW"}, {"id": "M4556", "name": "Asthma", "asFound": "Bronchial Asthma", "relevance": "HIGH"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC20", "name": "Immune System Diseases"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000019819", "term": "Budesonide"}, {"id": "D000069502", "term": "Budesonide, Formoterol Fumarate Drug Combination"}], "ancestors": [{"id": "D000018927", "term": "Anti-Asthmatic Agents"}, {"id": "D000019141", "term": "Respiratory System Agents"}, {"id": "D000000893", "term": "Anti-Inflammatory Agents"}, {"id": "D000001993", "term": "Bronchodilator Agents"}, {"id": "D000001337", "term": "Autonomic Agents"}, {"id": "D000018373", "term": "Peripheral Nervous System Agents"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000005938", "term": "Glucocorticoids"}, {"id": "D000006728", "term": "Hormones"}, {"id": "D000006730", "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"}], "browseLeaves": [{"id": "M21711", "name": "Budesonide", "asFound": "Helicobacter", "relevance": "HIGH"}, {"id": "M304", "name": "Formoterol Fumarate", "relevance": "LOW"}, {"id": "M452", "name": "Budesonide, Formoterol Fumarate Drug Combination", "asFound": "Early Stage", "relevance": "HIGH"}, {"id": "M20963", "name": "Anti-Asthmatic Agents", "relevance": "LOW"}, {"id": "M21137", "name": "Respiratory System Agents", "relevance": "LOW"}, {"id": "M4217", "name": "Anti-Inflammatory Agents", "relevance": "LOW"}, {"id": "M5269", "name": "Bronchodilator Agents", "relevance": "LOW"}, {"id": "M9047", "name": "Glucocorticoids", "relevance": "LOW"}, {"id": "M9789", "name": "Hormones", "relevance": "LOW"}, {"id": "M9788", "name": "Hormone Antagonists", "relevance": "LOW"}], "browseBranches": [{"abbrev": "Infl", "name": "Anti-Inflammatory Agents"}, {"abbrev": "Resp", "name": "Respiratory System Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}]}}, "hasResults": true}